{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:02:54Z","timestamp":1793023374071,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T00:00:00Z","timestamp":1552694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Foundation of Diabetes"},{"DOI":"10.13039\/501100010215","name":"German Diabetes Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010215","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Abbott"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12933-019-0837-x","type":"journal-article","created":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T09:03:27Z","timestamp":1552727007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4970-2110","authenticated-orcid":false,"given":"Peter","family":"Bramlage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Lanzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesine","family":"van Mark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Fahrner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph H. J.","family":"Heyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Friebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Seufert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Danne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard W.","family":"Holl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,16]]},"reference":[{"issue":"3","key":"837_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","volume":"94","author":"Y Xie","year":"2018","unstructured":"Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, Maddukuri G, Tsai CY, Floyd T, Al-Aly Z. Analysis of the global burden of disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94(3):567\u201381.","journal-title":"Kidney Int"},{"issue":"1","key":"837_CR2","first-page":"49","volume":"5","author":"O Gheith","year":"2016","unstructured":"Gheith O, Farouk N, Nampoory N, Halim MA, Al-Otaibi T. Diabetic kidney disease: world wide difference of prevalence and risk factors. J Nephropharmacol. 2016;5(1):49\u201356.","journal-title":"J Nephropharmacol"},{"key":"837_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/1756-0500-7-415","volume":"7","author":"RA Bailey","year":"2014","unstructured":"Bailey RA, Wang Y, Zhu V, Rupnow MF. Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on kidney disease: improving global outcomes (KDIGO) staging. BMC Res Notes. 2014;7:415.","journal-title":"BMC Res Notes"},{"issue":"12","key":"837_CR4","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"837_CR5","doi-asserted-by":"publisher","first-page":"e0147329","DOI":"10.1371\/journal.pone.0147329","volume":"11","author":"M Narres","year":"2016","unstructured":"Narres M, Claessen H, Droste S, Kvitkina T, Koch M, Kuss O, Icks A. The incidence of end-stage renal disease in the diabetic (compared to the non-diabetic) population: a systematic review. PLoS ONE. 2016;11(1):e0147329.","journal-title":"PLoS ONE"},{"issue":"3","key":"837_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jdiacomp.2017.12.003","volume":"32","author":"GA Nichols","year":"2018","unstructured":"Nichols GA, Deruaz-Luyet A, Hauske SJ, Brodovicz KG. The association between estimated glomerular filtration rate, albuminuria, and risk of cardiovascular hospitalizations and all-cause mortality among patients with type 2 diabetes. J Diabetes Complicat. 2018;32(3):291\u20137.","journal-title":"J Diabetes Complicat"},{"issue":"6","key":"837_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41581-018-0001-y","volume":"14","author":"HJ Anders","year":"2018","unstructured":"Anders HJ, Huber TB, Isermann B, Schiffer M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol. 2018;14(6):361\u201377.","journal-title":"Nat Rev Nephrol"},{"key":"837_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271\u201381.","journal-title":"Diabetes Res Clin Pract"},{"issue":"24","key":"837_CR9","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2011.861","volume":"305","author":"IH Boer de","year":"2011","unstructured":"de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011;305(24):2532\u20139.","journal-title":"JAMA"},{"issue":"1","key":"837_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12933-018-0787-8","volume":"17","author":"M Kosiborod","year":"2018","unstructured":"Kosiborod M, Gomes MB, Nicolucci A, Pocock S, Rathmann W, Shestakova MV, Watada H, Shimomura I, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Surmont F, Tang F, Khunti K, Investigators D. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Cardiovasc Diabetol. 2018;17(1):150.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"837_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1055\/s-0032-1327394","volume":"138","author":"T Wilke","year":"2013","unstructured":"Wilke T, Ahrendt P, Schwartz D, Linder R, Ahrens S, Verheyen F. Incidence and prevalence of type 2 diabetes mellitus in Germany: an analysis based on 5.43 million patients. Dtsch Med Wochenschr. 2013;138(3):69\u201375.","journal-title":"Dtsch Med Wochenschr"},{"issue":"7","key":"837_CR12","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1111\/j.1464-5491.2012.03578.x","volume":"29","author":"S Schipf","year":"2012","unstructured":"Schipf S, Werner A, Tamayo T, Holle R, Schunk M, Maier W, Meisinger C, Thorand B, Berger K, Mueller G, Moebus S, Bokhof B, Kluttig A, Greiser KH, Neuhauser H, Ellert U, Icks A, Rathmann W, Volzke H. Regional differences in the prevalence of known Type 2 diabetes mellitus in 45-74\u00a0years old individuals: results from six population-based studies in Germany (DIAB-CORE Consortium). Diabet Med. 2012;29(7):e88\u201395.","journal-title":"Diabet Med"},{"issue":"7","key":"837_CR13","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/dme.12747","volume":"32","author":"N Muller","year":"2015","unstructured":"Muller N, Heller T, Freitag MH, Gerste B, Haupt CM, Wolf G, Muller UA. Healthcare utilization of people with type 2 diabetes in Germany: an analysis based on health insurance data. Diabet Med. 2015;32(7):951\u20137.","journal-title":"Diabet Med"},{"issue":"8","key":"837_CR14","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/dme.12177","volume":"30","author":"R Waldeyer","year":"2013","unstructured":"Waldeyer R, Brinks R, Rathmann W, Giani G, Icks A. Projection of the burden of type 2 diabetes mellitus in Germany: a demographic modelling approach to estimate the direct medical excess costs from 2010 to 2040. Diabet Med. 2013;30(8):999\u20131008.","journal-title":"Diabet Med"},{"issue":"1","key":"837_CR15","doi-asserted-by":"publisher","first-page":"e000135","DOI":"10.1136\/bmjdrc-2015-000135","volume":"3","author":"Y Du","year":"2015","unstructured":"Du Y, Heidemann C, Schaffrath Rosario A, Buttery A, Paprott R, Neuhauser H, Riedel T, Icks A, Scheidt-Nave C. Changes in diabetes care indicators: findings from German national health interview and examination surveys 1997\u20131999 and 2008\u20132011. BMJ Open Diabetes Res Care. 2015;3(1):e000135.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"18","key":"837_CR16","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1055\/s-0033-1343144","volume":"138","author":"T Danne","year":"2013","unstructured":"Danne T, Kaltheuner M, Koch A, Ernst S, Rathmann W, Russmann HJ, Bramlage P, Studiengruppe D. \u201cDIabetes Versorgungs-Evaluation\u201d (DIVE)\u2014a national quality assurance initiative at physicians providing care for patients with diabetes. Dtsch Med Wochenschr. 2013;138(18):934\u20139.","journal-title":"Dtsch Med Wochenschr"},{"key":"837_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.diabres.2016.03.015","volume":"116","author":"P Bramlage","year":"2016","unstructured":"Bramlage P, Bluhmki T, Rathmann W, Kaltheuner M, Beyersmann J, Danne T, Group DS. Identifying patients with type 2 diabetes in which basal supported oral therapy may not be the optimal treatment strategy. Diabetes Res Clin Pract. 2016;116:127\u201335.","journal-title":"Diabetes Res Clin Pract"},{"key":"837_CR18","unstructured":"Ulm University. Diabetes-Patienten-Verlaufsdokumentation (DPV) \n                    http:\/\/buster.zibmt.uni-ulm.de\/dpv\/index.php\/en\/\n                    \n                  . Accessed 7 Jan 2019."},{"issue":"1","key":"837_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12933-016-0391-8","volume":"15","author":"B Bohn","year":"2016","unstructured":"Bohn B, Schofl C, Zimmer V, Hummel M, Heise N, Siegel E, Karges W, Riedl M, Holl RW. initiative DPV: achievement of treatment goals for secondary prevention of myocardial infarction or stroke in 29,325 patients with type 2 diabetes: a German\/Austrian DPV-multicenter analysis. Cardiovasc Diabetol. 2016;15(1):72.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"837_CR20","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.jpeds.2015.09.006","volume":"167","author":"KO Schwab","year":"2015","unstructured":"Schwab KO, Doerfer J, Hungele A, Scheuing N, Krebs A, Dost A, Rohrer TR, Hofer S, Holl RW. Non-high-density lipoprotein cholesterol in children with diabetes: proposed treatment recommendations based on glycemic control, body mass index, age, sex, and generally accepted cut points. J Pediatr. 2015;167(6):1436\u20139.","journal-title":"J Pediatr"},{"key":"837_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12902-015-0051-0","volume":"15","author":"T Danne","year":"2015","unstructured":"Danne T, Bluhmki T, Seufert J, Kaltheuner M, Rathmann W, Beyersmann J, Bramlage P, Group DS. Treatment intensification using long-acting insulin\u2013predictors of future basal insulin supported oral therapy in the DIVE registry. BMC Endocr Disord. 2015;15:54.","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"837_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2010.483","volume":"80","author":"AS Levey","year":"2011","unstructured":"Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011;80(1):17\u201328.","journal-title":"Kidney Int"},{"key":"837_CR23","doi-asserted-by":"crossref","unstructured":"KDIGO 2012. Clinical practice guideline for the evaluation and management of chronic kidney disease: Chapter 1: definition and classification of CKD. Kidney Int Suppl. 2013;3:19\u201362.","DOI":"10.1038\/kisup.2012.64"},{"issue":"9","key":"837_CR24","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.jdiacomp.2017.06.016","volume":"31","author":"A Schwandt","year":"2017","unstructured":"Schwandt A, Denkinger M, Fasching P, Pfeifer M, Wagner C, Weiland J, Zeyfang A, Holl RW. Comparison of MDRD, CKD-EPI, and Cockcroft\u2013Gault equation in relation to measured glomerular filtration rate among a large cohort with diabetes. J Diabetes Complicat. 2017;31(9):1376\u201383.","journal-title":"J Diabetes Complicat"},{"issue":"1","key":"837_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.diabres.2015.04.011","volume":"109","author":"MN Ozieh","year":"2015","unstructured":"Ozieh MN, Dismuke CE, Lynch CP, Egede LE. Medical care expenditures associated with chronic kidney disease in adults with diabetes: United States 2011. Diabetes Res Clin Pract. 2015;109(1):185\u201390.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"837_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jdiacomp.2013.09.014","volume":"28","author":"S Vupputuri","year":"2014","unstructured":"Vupputuri S, Kimes TM, Calloway MO, Christian JB, Bruhn D, Martin AA, Nichols GA. The economic burden of progressive chronic kidney disease among patients with type 2 diabetes. J Diabetes Complicat. 2014;28(1):10\u20136.","journal-title":"J Diabetes Complicat"},{"issue":"2","key":"837_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/aje\/kws466","volume":"178","author":"G Muller","year":"2013","unstructured":"Muller G, Kluttig A, Greiser KH, Moebus S, Slomiany U, Schipf S, Volzke H, Maier W, Meisinger C, Tamayo T, Rathmann W, Berger K. Regional and neighborhood disparities in the odds of type 2 diabetes: results from 5 population-based studies in Germany (DIAB-CORE consortium). Am J Epidemiol. 2013;178(2):221\u201330.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"837_CR28","first-page":"85","volume":"113","author":"M Girndt","year":"2016","unstructured":"Girndt M, Trocchi P, Scheidt-Nave C, Markau S, Stang A. The prevalence of renal failure. Results from the German health interview and examination survey for adults, 2008\u20132011 (DEGS1). Dtsch Arztebl Int. 2016;113(6):85\u201391.","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"837_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/ndt\/gfu294","volume":"30","author":"S Titze","year":"2015","unstructured":"Titze S, Schmid M, Kottgen A, Busch M, Floege J, Wanner C, Kronenberg F, Eckardt KU, Investigators GS. Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German chronic kidney disease (GCKD) cohort. Nephrol Dial Transplant. 2015;30(3):441\u201351.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"837_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12933-018-0753-5","volume":"17","author":"G Velho","year":"2018","unstructured":"Velho G, Ragot S, El Boustany R, Saulnier PJ, Fraty M, Mohammedi K, Fumeron F, Potier L, Marre M, Hadjadj S, Roussel R. Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes. Cardiovasc Diabetol. 2018;17(1):110.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"837_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12933-017-0569-8","volume":"16","author":"EH Zobel","year":"2017","unstructured":"Zobel EH, von Scholten BJ, Reinhard H, Persson F, Teerlink T, Hansen TW, Parving HH, Jacobsen PK, Rossing P. Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria. Cardiovasc Diabetol. 2017;16(1):88.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"837_CR32","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.2337\/db05-1620","volume":"55","author":"R Retnakaran","year":"2006","unstructured":"Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR. Risk factors for renal dysfunction in type 2 diabetes: UK prospective diabetes study 74. Diabetes. 2006;55(6):1832\u20139.","journal-title":"Diabetes"},{"issue":"1","key":"837_CR33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12933-018-0712-1","volume":"17","author":"ES Owusu Adjah","year":"2018","unstructured":"Owusu Adjah ES, Bellary S, Hanif W, Patel K, Khunti K, Paul SK. Prevalence and incidence of complications at diagnosis of T2DM and during follow-up by BMI and ethnicity: a matched case\u2013control analysis. Cardiovasc Diabetol. 2018;17(1):70.","journal-title":"Cardiovasc Diabetol"},{"key":"837_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13533","author":"S Low","year":"2018","unstructured":"Low S, Zhang X, Wang J, Yeoh LY, Liu YL, Ang SF, Subramaniam T, Sum CF, Lim SC. The impact of HbA1c trajectories on chronic kidney disease progression in type 2 diabetes. Nephrology (Carlton). 2018. \n                    https:\/\/doi.org\/10.1111\/nep.13533\n                    \n                  .","journal-title":"Nephrology (Carlton)"},{"issue":"1","key":"837_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12882-016-0273-z","volume":"17","author":"M Busch","year":"2016","unstructured":"Busch M, Nadal J, Schmid M, Paul K, Titze S, Hubner S, Kottgen A, Schultheiss UT, Baid-Agrawal S, Lorenzen J, Schlieper G, Sommerer C, Krane V, Hilge R, Kielstein JT, Kronenberg F, Wanner C, Eckardt KU, Wolf G, Investigators GS. Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease\u2014cross-sectional data from the German chronic kidney disease (GCKD) cohort. BMC Nephrol. 2016;17(1):59.","journal-title":"BMC Nephrol"},{"issue":"13","key":"837_CR36","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1001\/archinte.163.13.1555","volume":"163","author":"GL Bakris","year":"2003","unstructured":"Bakris GL, Weir MR, Shanifar S, Zhang Z, Douglas J, van Dijk DJ, Brenner BM. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med. 2003;163(13):1555\u201365.","journal-title":"Arch Intern Med"},{"issue":"10","key":"837_CR37","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1681\/ASN.2004110919","volume":"16","author":"MA Pohl","year":"2005","unstructured":"Pohl MA, Blumenthal S, Cordonnier DJ, De Alvaro F, Deferrari G, Eisner G, Esmatjes E, Gilbert RE, Hunsicker LG, de Faria JB, Mangili R, Moore J Jr, Reisin E, Ritz E, Schernthaner G, Spitalewitz S, Tindall H, Rodby RA, Lewis EJ. Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. J Am Soc Nephrol. 2005;16(10):3027\u201337.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"837_CR38","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.2337\/dc14-1296","volume":"37","author":"KR Tuttle","year":"2014","unstructured":"Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME. Diabetic kidney disease: a report from an ADA consensus conference. Diabetes Care. 2014;37(10):2864\u201383.","journal-title":"Diabetes Care"},{"issue":"12","key":"837_CR39","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861\u20139.","journal-title":"N Engl J Med"},{"issue":"20","key":"837_CR40","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","volume":"369","author":"LF Fried","year":"2013","unstructured":"Fried LF, Emanuele N, Zhang JH, Brophy M, Conner TA, Duckworth W, Leehey DJ, McCullough PA, O\u2019Connor T, Palevsky PM, Reilly RF, Seliger SL, Warren SR, Watnick S, Peduzzi P, Guarino P. Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med. 2013;369(20):1892\u2013903.","journal-title":"N Engl J Med"},{"issue":"9638","key":"837_CR41","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","volume":"372","author":"JF Mann","year":"2008","unstructured":"Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsarinne K, Oto A, Parkhomenko A, Piegas LS, Svendsen TL, Teo KK, Yusuf S. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet. 2008;372(9638):547\u201353.","journal-title":"Lancet"},{"issue":"9","key":"837_CR42","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.2337\/diacare.28.9.2106","volume":"28","author":"K Rossing","year":"2005","unstructured":"Rossing K, Schjoedt KJ, Smidt UM, Boomsma F, Parving HH. Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study. Diabetes Care. 2005;28(9):2106\u201312.","journal-title":"Diabetes Care"},{"issue":"5","key":"837_CR43","doi-asserted-by":"publisher","first-page":"940","DOI":"10.2215\/CJN.00240106","volume":"1","author":"M Epstein","year":"2006","unstructured":"Epstein M, Williams GH, Weinberger M, Lewin A, Krause S, Mukherjee R, Patni R, Beckerman B. Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes. Clin J Am Soc Nephrol. 2006;1(5):940\u201351.","journal-title":"Clin J Am Soc Nephrol"},{"key":"837_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007004.pub3","author":"D Bolignano","year":"2014","unstructured":"Bolignano D, Palmer SC, Navaneethan SD, Strippoli GF. Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2014. \n                    https:\/\/doi.org\/10.1002\/14651858.CD007004.pub3\n                    \n                  .","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"837_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s42000-018-0014-8","volume":"17","author":"VG Athyros","year":"2018","unstructured":"Athyros VG, Doumas M, Imprialos KP, Stavropoulos K, Georgianou E, Katsimardou A, Karagiannis A. Diabetes and lipid metabolism. Hormones (Athens). 2018;17(1):61\u20137.","journal-title":"Hormones (Athens)"},{"issue":"9","key":"837_CR46","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1161\/CIRCULATIONAHA.113.002529","volume":"129","author":"FM Sacks","year":"2014","unstructured":"Sacks FM, Hermans MP, Fioretto P, Valensi P, Davis T, Horton E, Wanner C, Al-Rubeaan K, Aronson R, Barzon I, Bishop L, Bonora E, Bunnag P, Chuang LM, Deerochanawong C, Goldenberg R, Harshfield B, Hernandez C, Herzlinger-Botein S, Itoh H, Jia W, Jiang YD, Kadowaki T, Laranjo N, Leiter L, Miwa T, Odawara M, Ohashi K, Ohno A, Pan C, Pan J, Pedro-Botet J, Reiner Z, Rotella CM, Simo R, Tanaka M, Tedeschi-Reiner E, Twum-Barima D, Zoppini G, Carey VJ. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case\u2013control study in 13 countries. Circulation. 2014;129(9):999\u20131008.","journal-title":"Circulation"},{"issue":"1","key":"837_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00045.2011","volume":"93","author":"JM Forbes","year":"2013","unstructured":"Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137\u201388.","journal-title":"Physiol Rev"},{"issue":"3","key":"837_CR48","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/j.ackd.2014.03.003","volume":"21","author":"R Palsson","year":"2014","unstructured":"Palsson R, Patel UD. Cardiovascular complications of diabetic kidney disease. Adv Chronic Kidney Dis. 2014;21(3):273\u201380.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"2","key":"837_CR49","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1681\/ASN.2012070718","volume":"24","author":"M Afkarian","year":"2013","unstructured":"Afkarian M, Sachs MC, Kestenbaum B, Hirsch IB, Tuttle KR, Himmelfarb J, de Boer IH. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol. 2013;24(2):302\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"837_CR50","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1111\/dme.12062","volume":"30","author":"W Maier","year":"2013","unstructured":"Maier W, Holle R, Hunger M, Peters A, Meisinger C, Greiser KH, Kluttig A, Volzke H, Schipf S, Moebus S, Bokhof B, Berger K, Mueller G, Rathmann W, Tamayo T, Mielck A. The impact of regional deprivation and individual socio-economic status on the prevalence of Type 2 diabetes in Germany. A pooled analysis of five population-based studies. Diabet Med. 2013;30(3):e78\u201386.","journal-title":"Diabet Med"},{"issue":"3","key":"837_CR51","doi-asserted-by":"publisher","first-page":"e020145","DOI":"10.1136\/bmjopen-2017-020145","volume":"8","author":"R Mathur","year":"2018","unstructured":"Mathur R, Dreyer G, Yaqoob MM, Hull SA. Ethnic differences in the progression of chronic kidney disease and risk of death in a UK diabetic population: an observational cohort study. BMJ Open. 2018;8(3):e020145.","journal-title":"BMJ Open"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-019-0837-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12933-019-0837-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-019-0837-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T02:48:20Z","timestamp":1590029300000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-019-0837-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,16]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["837"],"URL":"https:\/\/doi.org\/10.1186\/s12933-019-0837-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,16]]},"assertion":[{"value":"22 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"33"}}